Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Boston Scientific Corporation
- License Information
-
More Information
Article History
Received: 2 April 2025
Accepted: 26 July 2025
First Online: 29 July 2025
Declarations
:
: Kevin McVary discloses consultancy and PI for Astellas, Boston Scientific, NIDDK, Merck, UroNext, Olympus, and SRS Medical Systems. Bronwyn Long reports no conflicts of interest. Amandip Cheema reports no conflicts of interest. Larry Miller discloses consultancy with Boston Scientific.
: Institutional Review Board approval was obtained for the included studies.
: Written informed consent was obtained from all participants before inclusion in the studies.
